CLINICAL_TRIALS
trial_result
· 2023-05-11
Clinical Trial Update: Safety and Exploratory Efficacy Study of SF0166 for the Treatment of Diabetic Macular Edema (DME) [Phase 1, Phase 2]
Summary
Clinical trial update for SF0166 in diabetic macular edema reports completed Phase 1/2 with safety and exploratory efficacy data.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: OcuTerra Therapeutics, Inc. | Conditions: Diabetic Macular Edema | Phase 1, Phase 2 | Status: COMPLETED | Results posted: 2023-05-11